Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3...

Statement of Cash Flows—Indirect Method

The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows:

		Dec. 31, 20Y3	Dec. 31, 20Y2
Assets
Cash		$301,740	$281,660
Accounts receivable (net)		109,310	101,160
Inventories		308,580	299,510
Investments		0	116,040
Land		158,270	0
Equipment		340,460	264,800
Accumulated depreciation—equipment		(79,710)	(71,410)
	Total assets	$1,138,650	$991,760

Liabilities and Stockholders' Equity
Accounts payable (merchandise creditors)		$206,100	$195,380
Accrued expenses payable (operating expenses)		20,500	25,790
Dividends payable		11,390	8,930
Common stock, $10 par		61,490	48,600
Paid-in capital: Excess of issue price over par-common stock		231,150	134,880
Retained earnings		608,020	578,180
	Total liabilities and stockholders’ equity	$1,138,650	$991,760

Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows:

The investments were sold for $135,770 cash.
Equipment and land were acquired for cash.
There were no disposals of equipment during the year.
The common stock was issued for cash.
There was a $76,450 credit to Retained Earnings for net income.
There was a $46,610 debit to Retained Earnings for cash dividends declared.

Required:

Prepare a statement of cash flows, using the indirect method of presenting cash flows from operating activities. Use the minus sign to indicate cash out flows, cash payments, decreases in cash, or any negative adjustments.

Livers Inc.
Statement of Cash Flows
For the Year Ended December 31, 20Y3
Cash flows from operating activities:
	$
Adjustments to reconcile net income to net cash flow from operating activities:


Changes in current operating assets and liabilities:




Net cash flow from operating activities		$
Cash flows from investing activities:
	$


Net cash flow used for investing activities
Cash flows from financing activities:
	$

Net cash flow from financing activities
		$
Cash at the beginning of the year
Cash at the end of the year		$

Solutions

Expert Solution

Cash Flow Statement (indirect):
	Amount $
Cash from Operating Activities:

Net Income	76450
Add:Depreciation	8300
Less:Income on Investment sale	-19730	135770-116040
less: Inc. in AR	-8150	109310-101160
less: Inc. in Inv.	-9070	308580-299510
add: Inc. in AP	10720	206100-195380
less: Dec. in Acc Exp.	-5290	20500-25790
add: Inc. in DP	2460	11390-8930
Cash Inflow of Operating Activities	55690

Cash from Investing Activities:

Add: Sale in Investment	135770
Less:Purch. Of equip	-75660	340460-264800
Less:Purch. Of land	-158270
Cash outflow of Investing Activities	-98160

Cash from Financing Activities:

Add:issue of CS	12890
Add: Additional capital received	96270
Less:Dividend paid	-46610
Cash inflow of Financing Activities	62550

Net Cash inflow of all activities	20080
Add: Opening Cash	281660
Closing Cash	301740

ekkarill92 answered 7 months ago

Next > < Previous

Related Solutions

Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3...

Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $300,080 $277,530 Accounts receivable (net) 108,710 99,680 Inventories 306,860 295,120 Investments 0 114,340 Land 157,400 0 Equipment 338,580 260,920 Accumulated depreciation—equipment (79,270) (70,360) Total assets $1,132,360 $977,230 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $204,960 $192,510 Accrued expenses payable (operating expenses) 20,380 25,410 Dividends payable 11,320 8,800 Common stock,...

Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3...

Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $222,990 $209,100 Accounts receivable (net) 80,780 75,100 Inventories 228,030 222,360 Investments 0 86,140 Land 116,960 0 Equipment 251,600 196,590 Accumulated depreciation—equipment (58,900) (53,010) Total assets $841,460 $736,280 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $152,300 $145,050 Accrued expenses payable (operating expenses) 15,150 19,140 Dividends payable 8,410 6,630 Common stock,...

Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3...

Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $256,050 $240,660 Accounts receivable (net) 92,760 86,430 Inventories 261,850 255,910 Investments 0 99,140 Land 134,310 0 Equipment 288,900 226,250 Accumulated depreciation—equipment (67,640) (61,010) Total assets $966,230 $847,380 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $174,890 $166,930 Accrued expenses payable (operating expenses) 17,390 22,030 Dividends payable 9,660 7,630 Common stock,...

Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3...

Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $292,970 $275,040 Accounts receivable (net) 106,130 98,780 Inventories 299,610 292,480 Investments 0 113,310 Land 153,670 0 Equipment 330,560 258,580 Accumulated depreciation—equipment (77,390) (69,730) Total assets $1,105,550 $968,460 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $200,100 $190,790 Accrued expenses payable (operating expenses) 19,900 25,180 Dividends payable 11,060 8,720 Common stock,...

Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3...

Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $313,010 $292,180 Accounts receivable (net) 113,390 104,940 Inventories 320,110 310,700 Investments 0 120,370 Land 164,180 0 Equipment 353,170 274,690 Accumulated depreciation—equipment (82,680) (74,070) Total assets $1,181,180 $1,028,810 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $213,790 $202,680 Accrued expenses payable (operating expenses) 21,260 26,750 Dividends payable 11,810 9,260 Common stock,...

Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3...

Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $241,460 $226,680 Accounts receivable (net) 87,470 81,410 Inventories 246,920 241,060 Investments 0 93,390 Land 126,650 0 Equipment 272,440 213,110 Accumulated depreciation—equipment (63,780) (57,470) Total assets $911,160 $798,180 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $164,920 $157,240 Accrued expenses payable (operating expenses) 16,400 20,750 Dividends payable 9,110 7,180 Common stock,...

Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3...

Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $291,640 $273,170 Accounts receivable (net) 105,650 98,110 Inventories 298,250 290,480 Investments 0 112,540 Land 152,980 0 Equipment 329,060 256,820 Accumulated depreciation—equipment (77,040) (69,250) Total assets $1,100,540 $961,870 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $199,200 $189,490 Accrued expenses payable (operating expenses) 19,810 25,010 Dividends payable 11,010 8,660 Common stock,...

Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3...

Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $256,770 $237,750 Accounts receivable (net) 93,020 85,390 Inventories 262,580 252,830 Investments 0 97,950 Land 134,680 0 Equipment 289,710 223,520 Accumulated depreciation—equipment (67,830) (60,280) Total assets $968,930 $837,160 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $175,380 $164,920 Accrued expenses payable (operating expenses) 17,440 21,770 Dividends payable 9,690 7,530 Common stock,...

DIRECT METHOD The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is...

DIRECT METHOD The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $625,820.00 $586,050.00 4 Accounts receivable (net) 227,530.00 209,880.00 5 Inventories 641,480.00 616,920.00 6 Investments 0.00 240,910.00 7 Land 327,510.00 0.00 8 Equipment 704,830.00 554,110.00 9 Accumulated depreciation-equipment (165,750.00) (148,570.00) 10 Total assets $2,361,420.00 $2,059,300.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $424,970.00 $405,330.00 13 Accrued expenses payable (operating...

Sole the follwing problem Statement of cash flows—indirect method The comparative balance sheet of Livers Inc....

Sole the follwing problem Statement of cash flows—indirect method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $625,650.00 $586,340.00 4 Accounts receivable (net) 228,170.00 208,030.00 5 Inventories 641,480.00 617,130.00 6 Investments 0.00 240,290.00 7 Land 328,170.00 0.00 8 Equipment 706,070.00 552,300.00 9 Accumulated depreciation-equipment (165,580.00) (147,010.00) 10 Total assets $2,363,960.00 $2,057,080.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise...

Subjects